Search - tctmd.com

Displaying 161 - 180 of 232

Sort: Relevancy | Date

Presentation CDM 2017

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

Presenter: John D. Carroll

October 06, 2017

Presentation CHIP Seattle 2017

How a CHIP Operator Manages Saphenous Vein Graft (SVG) Disease

Presenter: John M. Lasala

August 11, 2017

Presentation SOLACI 2017

Role of Embolic Protection during TAVR

Presenter: Samir Kapadia

August 02, 2017

Presentation TVT 2017

The SENTINEL Trial: Safety and Effectiveness of Cerebral Embolic Protection During TAVR

Presenter: Axel Linke, Jeffrey J. Popma, Susheel Kodali

June 15, 2017

Presentation TVT 2017

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

Presenter: Alexandra J. Lansky, Nicolas M. Van Mieghem, Michael J. Mack

June 15, 2017

Presentation TVT 2017

A Description of the U.S. REFLECT Randomized Clinical Trial

Presenter: Jeffrey W. Moses

June 15, 2017

Presentation TVT 2017

Device Design Features and Findings From EU Clinical Trials

Presenter: Joachim Schofer

June 15, 2017

Presentation TVT 2017

A Propensity Score Analysis of Matched TAVR Patients With and Without Cerebral Protection

Presenter: Jochen Wöhrle

June 15, 2017

Presentation TVT 2017

Device Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

Presenter: Axel Linke

June 15, 2017

Presentation TVT 2017

The Compelling Saga of Strokes After TAVR (and SAVR): Diagnosis Considerations and Key Messages From NeuroARC

Presenter: Alexandra J. Lansky, Nicolas M. Van Mieghem

June 15, 2017

Presentation Fellows 2017

Thrombectomy, Embolic Protection Systems, and SVG Intervention

Presenter: Ajay J. Kirtane, Emmanouil S. Brilakis

April 08, 2017

Presentation ACC 2017

Cerebral Embolic Protection In Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

Presenter: Michael Mack

March 20, 2017

Presentation JIM 2017

Complete Cerebral Embolic Protection Utilizing TriGuard™

Presenter: Azeem Latib

February 10, 2017

Presentation TCT 2016

Cerebral Embolic Protection II: The Keystone Deflector - Design Features and Updates From Deflect III and Reflect Clinical Trials

Presenter: Helene Eltchaninoff, Neal S. Kleiman, Andreas Baumbach

November 01, 2016

Presentation TCT 2016

Cerebral Embolic Protection I: The Sentinel Filter - Design Features and Updates from CLEAN-TAVI, SENTINEL RCT, and Others

Presenter: Helene Eltchaninoff, Neal S. Kleiman, Axel Linke

November 01, 2016

Presentation TCT 2016

Debate: What Is the Optimal Technique for Embolic Protection During Carotid Stenting? Proximal Embolic Protection Isnt Enough Transcervical Access With Flow Reversal Is the Ideal Strategy for CAS

Presenter: Sriram S. Iyer, John R. Laird Jr., Brian G. DeRubertis

November 01, 2016

Presentation TCT 2016

Debate: What Is the Optimal Technique for Embolic Protection During Carotid Stenting? Distal Embolic Protection With Contemporary Devices and Techniques Provides Optimal CAS Outcomes

Presenter: Sriram S. Iyer, John R. Laird Jr., William A. Gray

November 01, 2016

Presentation TCT 2016

Controversy 1. Is Cerebral Embolic Protection Needed for TAVR? The Evidence: Observations From DEFLECT 3, CLEAN-TAVI, and the SENTINEL Clinical Trials

Presenter: Raj Makkar, Lars Sondergaard, Samir R. Kapadia

October 31, 2016

Presentation TCT 2016

Editorial Perspective: Embolic Protection in TAVR Intervention

Presenter: Josep Rodés-Cabau

October 31, 2016

Presentation TCT 2016

Double-edged Sealing Embolic Protection Device (Transverse)

Presenter: Eric Goslau

October 31, 2016

Advertisement

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

How a CHIP Operator Manages Saphenous Vein Graft (SVG) Disease

Role of Embolic Protection during TAVR

The SENTINEL Trial: Safety and Effectiveness of Cerebral Embolic Protection During TAVR

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

A Description of the U.S. REFLECT Randomized Clinical Trial

Device Design Features and Findings From EU Clinical Trials

A Propensity Score Analysis of Matched TAVR Patients With and Without Cerebral Protection

Device Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

The Compelling Saga of Strokes After TAVR (and SAVR): Diagnosis Considerations and Key Messages From NeuroARC

Thrombectomy, Embolic Protection Systems, and SVG Intervention

Cerebral Embolic Protection In Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

Complete Cerebral Embolic Protection Utilizing TriGuard™

Cerebral Embolic Protection II: The Keystone Deflector - Design Features and Updates From Deflect III and Reflect Clinical Trials

Cerebral Embolic Protection I: The Sentinel Filter - Design Features and Updates from CLEAN-TAVI, SENTINEL RCT, and Others

Debate: What Is the Optimal Technique for Embolic Protection During Carotid Stenting? Proximal Embolic Protection Isnt Enough Transcervical Access With Flow Reversal Is the Ideal Strategy for CAS

Debate: What Is the Optimal Technique for Embolic Protection During Carotid Stenting? Distal Embolic Protection With Contemporary Devices and Techniques Provides Optimal CAS Outcomes

Controversy 1. Is Cerebral Embolic Protection Needed for TAVR? The Evidence: Observations From DEFLECT 3, CLEAN-TAVI, and the SENTINEL Clinical Trials

Editorial Perspective: Embolic Protection in TAVR Intervention

Double-edged Sealing Embolic Protection Device (Transverse)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content